Fresh Equities
ASX:PAR

ASX:PAR

PARADIGM BIOPHARMACEUTICALS LIMITED

PARADIGM BIOPHARMACEUTICALS LIMITED has not announced any capital raises, but we are collecting interest for future raises.

Demand Registered for Next Raise
$50k - 100k
Investors Interested in Next Raise
< 10
How Fresh Equities Works
Authentication

1. Create Account

Complete your onboarding digitally in less than 3 minutes.

Authentication

2. View Terms

View the full term sheet for the capital raise.

Authentication

3. Bid for Allocation

Submit and track your bid online.

Capital Raise History

22 October 2018

Placement

15 April 2019

Placement
Raised
$51.6m
Offer Price
$1.5
Discount
21.05%
Price at Close
$1.9
Market Cap
$266.56m
Re-listed
8 months ago

Company Overview

Paradigm Biopharmaceuticals Limited (PAR) is an Australian biopharmaceutical company focused on repurposing the drug 'pentosan polysulphate sodium' (PPS) for the treatment of bone marrow edema. Paradigm is targeting addressable markets with the aim to use the shortened development pathway utilising repurposed drugs.

Type

Listed Company

GICS Sub-industry

Biotechnology

Head Office

Level 2/517 Flinders Ln, Melbourne VIC 3000, Australia

Biotechnology
Health Care
Biotech
Osteoarthritis
Biotech & Health

Quarterly Cash Flows

The numbers below are derived from quarterly cash flow reports provided by the company. Fresh Equities does not guarantee that the information provided is accurate, you can read the associated report by clicking read more for the quarter. Always do your own research and do not rely on the information provided here as your only source of research.

Loading...


Directors


Announcements

Past 24 Hours

Fresh Equities does not have PARADIGM BIOPHARMACEUTICALS LIMITED announcements data.


News

Loading...